3.35 USD
+0.06 (+1.82%)
Last: Feb 10, 2026, 12:30 PM
Taking everything into account, CURI scores 4 out of 10 in our fundamental rating. CURI was compared to 80 industry peers in the Entertainment industry. While CURI seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, CURI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- In the past year CURI has reported negative net income.
- In the past year CURI had a positive cash flow from operations.
- In the past 5 years CURI always reported negative net income.
- In the past 5 years CURI reported 4 times negative operating cash flow.
1.2 Ratios
- CURI's Return On Assets of -7.30% is on the low side compared to the rest of the industry. CURI is outperformed by 66.25% of its industry peers.
- Looking at the Return On Equity, with a value of -11.56%, CURI is in line with its industry, outperforming 45.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.3% | ||
| ROE | -11.56% | ||
| ROIC | N/A |
ROA(3y)-32.15%
ROA(5y)-36.84%
ROE(3y)-44.33%
ROE(5y)-58.97%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- CURI's Gross Margin of 54.50% is fine compared to the rest of the industry. CURI outperforms 61.25% of its industry peers.
- CURI's Gross Margin has been stable in the last couple of years.
- CURI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.5% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- CURI does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, CURI has more shares outstanding
- The number of shares outstanding for CURI has been increased compared to 5 years ago.
- CURI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- CURI has an Altman-Z score of -1.16. This is a bad value and indicates that CURI is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of CURI (-1.16) is worse than 72.50% of its industry peers.
- There is no outstanding debt for CURI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | -1.16 |
ROIC/WACCN/A
WACC9.77%
2.3 Liquidity
- A Current Ratio of 1.62 indicates that CURI should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.62, CURI is in the better half of the industry, outperforming 71.25% of the companies in the same industry.
- CURI has a Quick Ratio of 1.62. This is a normal value and indicates that CURI is financially healthy and should not expect problems in meeting its short term obligations.
- CURI has a better Quick ratio (1.62) than 72.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 |
3. Growth
3.1 Past
- CURI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.86%, which is quite impressive.
- The Revenue has grown by 28.62% in the past year. This is a very strong growth!
- Measured over the past years, CURI shows a very negative growth in Revenue. The Revenue has been decreasing by -10.47% on average per year.
EPS 1Y (TTM)67.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)28.62%
Revenue growth 3Y-10.47%
Revenue growth 5YN/A
Sales Q2Q%45.66%
3.2 Future
- Based on estimates for the next years, CURI will show a very strong growth in Earnings Per Share. The EPS will grow by 50.40% on average per year.
- The Revenue is expected to grow by 13.02% on average over the next years. This is quite good.
EPS Next Y68.12%
EPS Next 2Y44.4%
EPS Next 3Y36.66%
EPS Next 5Y50.4%
Revenue Next Year41.59%
Revenue Next 2Y23.63%
Revenue Next 3Y21.34%
Revenue Next 5Y13.02%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- CURI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- With a Price/Forward Earnings ratio of 164.22, CURI can be considered very expensive at the moment.
- CURI's Price/Forward Earnings ratio is in line with the industry average.
- Compared to an average S&P500 Price/Forward Earnings ratio of 27.86, CURI is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 164.22 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CURI is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, CURI is valued cheaply inside the industry as 91.25% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.21 | ||
| EV/EBITDA | 18.96 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CURI does not grow enough to justify the current Price/Earnings ratio.
- CURI's earnings are expected to grow with 36.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.4%
EPS Next 3Y36.66%
5. Dividend
5.1 Amount
- CURI has a Yearly Dividend Yield of 10.09%, which is a nice return.
- In the last 3 months the price of CURI has falen by -27.85%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- CURI's Dividend Yield is rather good when compared to the industry average which is at 7.58. CURI pays more dividend than 95.00% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.80, CURI pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.09% |
5.2 History
- CURI is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- CURI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-342.83%
EPS Next 2Y44.4%
EPS Next 3Y36.66%
NASDAQ:CURI (2/10/2026, 12:30:59 PM)
3.35
+0.06 (+1.82%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-09 2026-03-09/amc
Inst Owners33.27%
Inst Owner Change-1.11%
Ins Owners7.76%
Ins Owner Change1.09%
Market Cap195.31M
Revenue(TTM)66.59M
Net Income(TTM)-5.45M
Analysts86
Price Target6.63 (97.91%)
Short Float %5.11%
Short Ratio3.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.09% |
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP-342.83%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)11.44%
Min Revenue beat(2)9.49%
Max Revenue beat(2)13.4%
Revenue beat(4)3
Avg Revenue beat(4)6.66%
Min Revenue beat(4)-0.09%
Max Revenue beat(4)13.4%
Revenue beat(8)3
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)-2.28%
Revenue beat(16)8
Avg Revenue beat(16)-1.46%
PT rev (1m)0%
PT rev (3m)3.38%
EPS NQ rev (1m)-20%
EPS NQ rev (3m)-140%
EPS NY rev (1m)-25%
EPS NY rev (3m)-233.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 164.22 | ||
| P/S | 2.93 | ||
| P/FCF | 16.21 | ||
| P/OCF | 16.11 | ||
| P/B | 4.14 | ||
| P/tB | 10.22 | ||
| EV/EBITDA | 18.96 |
EPS(TTM)-0.09
EYN/A
EPS(NY)0.02
Fwd EY0.61%
FCF(TTM)0.21
FCFY6.17%
OCF(TTM)0.21
OCFY6.21%
SpS1.14
BVpS0.81
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.3% | ||
| ROE | -11.56% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.5% | ||
| FCFM | 18.09% |
ROA(3y)-32.15%
ROA(5y)-36.84%
ROE(3y)-44.33%
ROE(5y)-58.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5YN/A
F-Score7
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 0.5% | ||
| Cap/Sales | 0.12% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 152.89% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 | ||
| Altman-Z | -1.16 |
F-Score7
WACC9.77%
ROIC/WACCN/A
Cap/Depr(3y)0.12%
Cap/Depr(5y)1.04%
Cap/Sales(3y)0.06%
Cap/Sales(5y)0.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y68.12%
EPS Next 2Y44.4%
EPS Next 3Y36.66%
EPS Next 5Y50.4%
Revenue 1Y (TTM)28.62%
Revenue growth 3Y-10.47%
Revenue growth 5YN/A
Sales Q2Q%45.66%
Revenue Next Year41.59%
Revenue Next 2Y23.63%
Revenue Next 3Y21.34%
Revenue Next 5Y13.02%
EBIT growth 1Y43.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year188.9%
EBIT Next 3Y51.92%
EBIT Next 5Y26.01%
FCF growth 1Y153.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y154.1%
OCF growth 3YN/A
OCF growth 5YN/A
CURIOSITYSTREAM INC / CURI FAQ
What is the fundamental rating for CURI stock?
ChartMill assigns a fundamental rating of 4 / 10 to CURI.
What is the valuation status for CURI stock?
ChartMill assigns a valuation rating of 3 / 10 to CURIOSITYSTREAM INC (CURI). This can be considered as Overvalued.
Can you provide the profitability details for CURIOSITYSTREAM INC?
CURIOSITYSTREAM INC (CURI) has a profitability rating of 1 / 10.
How sustainable is the dividend of CURIOSITYSTREAM INC (CURI) stock?
The dividend rating of CURIOSITYSTREAM INC (CURI) is 4 / 10 and the dividend payout ratio is -342.83%.